What is he best known for?
The fields of study he is best known for:
- Organic chemistry
- Enzyme
- Dopamine
The scientist’s investigation covers issues in Agonist, Stereochemistry, Pharmacology, Dopamine and Dopamine receptor D2.
His study in Agonist is interdisciplinary in nature, drawing from both Dopaminergic, Dopamine receptor D3, Endocrinology and Postsynaptic potential.
His research in Stereochemistry intersects with topics in Selectivity, Ligand and Cytotoxicity.
He combines subjects such as Haloperidol, Tiospirone and Antipsychotic with his study of Pharmacology.
Håkan Wikström works mostly in the field of Dopamine, limiting it down to topics relating to Autoreceptor and, in certain cases, Piperidine.
His study connects Dopamine receptor and Dopamine receptor D2.
His most cited work include:
- 8-hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity (492 citations)
- Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]WAY-100635 (253 citations)
- 3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors (210 citations)
What are the main themes of his work throughout his whole career to date?
Håkan Wikström mainly investigates Stereochemistry, Agonist, Receptor, Pharmacology and Dopamine.
His Stereochemistry research is multidisciplinary, relying on both Tertiary amine, Dopaminergic and Chemical synthesis.
The Agonist study which covers Dopamine receptor D2 that intersects with Neurotransmitter.
As part of his studies on Receptor, Håkan Wikström often connects relevant areas like Neuroscience.
His Pharmacology study which covers Amphetamine that intersects with Primate.
His Dopamine research is multidisciplinary, incorporating elements of Postsynaptic potential and Autoreceptor.
He most often published in these fields:
- Stereochemistry (36.91%)
- Agonist (34.90%)
- Receptor (34.23%)
What were the highlights of his more recent work (between 2001-2013)?
- Receptor (34.23%)
- Pharmacology (32.89%)
- Agonist (34.90%)
In recent papers he was focusing on the following fields of study:
Håkan Wikström mostly deals with Receptor, Pharmacology, Agonist, Dopamine receptor D2 and Radioligand.
His studies in Receptor integrate themes in fields like Carbon and Enantiomer, Stereochemistry.
The study incorporates disciplines such as Chemical synthesis and 5-HT7 receptor in addition to Stereochemistry.
Much of his study explores Pharmacology relationship to Dyskinesia.
He focuses mostly in the field of Agonist, narrowing it down to topics relating to Endocrinology and, in certain cases, Scatchard plot.
His Radioligand study combines topics in areas such as Yield, Antagonist, Receptor antagonist, 5-HT receptor and Piperazine.
Between 2001 and 2013, his most popular works were:
- Comparison between electrochemistry/mass spectrometry and cytochrome P450 catalyzed oxidation reactions. (157 citations)
- Inactivation of 5-HT2C receptors potentiates consequences of serotonin reuptake blockade (129 citations)
- Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: A comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride (108 citations)
In his most recent research, the most cited papers focused on:
- Organic chemistry
- Enzyme
- Dopamine
Håkan Wikström mainly focuses on Endocrinology, Internal medicine, Agonist, Dopamine receptor D2 and Pharmacology.
His work focuses on many connections between Agonist and other disciplines, such as Raclopride, that overlap with his field of interest in Apomorphine, Binding potential and Radioligand.
While the research belongs to areas of Radioligand, he spends his time largely on the problem of Ethylamine, intersecting his research to questions surrounding Stereochemistry.
His Dopamine receptor D2 study is associated with Receptor.
His biological study deals with issues like Dopamine, which deal with fields such as 5-HT receptor.
His studies deal with areas such as Citalopram and Serotonin as well as Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
